SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as investors react to the FDA accepting its supplemental BLA for the label expansion of Anktiva, setting a PDUFA date for early January 2027. Community discussion is heavily focused on the stock's significant short interest and the potential for a squeeze, with many longs pointing to the recent NCCN guideline updates and comparative clinical data as drivers for long-term growth despite near-term volatility.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is currently trending as investors debate the potential for a turnaround, fueled by recent insider buying, rumors of favorable tariff adjustments, and anticipation for the upcoming World Cup. While some market participants express deep pessimism over declining margins and market share, others are actively accumulating shares as a long-term value play at multi-year lows.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is currently the focal point of the market as investors anxiously await earnings results that many view as a critical bellwether for the entire AI infrastructure sector. The community is heavily divided, with intense debate over whether the stock will repeat its historical pattern of post-earnings selling or if it will catalyze a significant, sustained rally that boosts broader tech valuations.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

iShares Silver Trust is experiencing significant volatility and a sharp pullback as traders react to a broader market sell-off, surging bond yields, and persistent uncertainty surrounding global energy prices. While some community members are treating the drop as a long-term accumulation opportunity, many others are actively debating whether this signals a major trend reversal or if price manipulation is being used to clear out retail call positions.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors anticipate the final REGAL trial unblinding, with bullish sentiment fueled by management's recent commentary regarding extended GPS survival outcomes and its potential to outcompete existing maintenance therapies. The community is actively discussing an imminent short squeeze driven by heavy short interest and institutional accumulation, while emphasizing the importance of holding shares and avoiding stop-loss orders in anticipation of a transformative data readout.

NIO, Inc. operates as a holding company, which engages in the design, development, manufacture, and sale of smart electric vehicles. It offers its products under the brands NIO, ONVO, and FIREFLY. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Shanghai, China.

NIO Inc - ADR

NIO Inc

NIO is trending as investors weigh significant analyst upgrades and record stake increases from major institutions against persistent concerns regarding market manipulation and the competitive EV landscape in China. The community remains deeply polarized, with many retail shareholders expressing extreme frustration over the stock's long-term performance while others aggressively accumulate shares in anticipation of a potential short squeeze following the upcoming earnings report.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target is trending as investors react to a significant earnings beat and an optimistic full-year outlook, fueling debate over the company's turnaround progress under its new leadership. The community is actively discussing the stock's recent price recovery, comparing it to rival Walmart, and debating whether the rebound is a sustainable shift or a potential overextension.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA Group is trending sharply higher after reporting strong quarterly earnings and raising its full-year guidance, which has fueled intense community discussion regarding its rapid expansion and market share growth. While bulls are highlighting the restaurant chain's robust same-store sales and healthy balance sheet as indicators for long-term potential, skeptics are actively debating whether the stock's premium valuation is sustainable in the current macro environment.

Analog Devices, Inc. is a semiconductor company, which engages in the combination of analog, digital, and software technologies into engineering solutions. Its products include analog and mixed signals, power management and reference, amplifiers radio frequency, and reference, sensors and actuators, and digital signal processing and system. The company was founded by Raymond P. Stata and Matthew Lorber in 1965 and is headquartered in Wilmington, MA.

Analog Devices Inc.

Analog Devices is trending following a strong quarterly performance where the company delivered a double beat on earnings and revenue, signaling a robust recovery in the analog semiconductor sector. Investors are particularly focused on the company's strategic acquisition of Empower Semiconductor to bolster its AI power delivery capabilities and its positive growth outlook across industrial and communications markets.

Keysight Technologies, Inc. engages in the provision of electronic design and test solutions that are used in the design, development, manufacture, installation, deployment, validation, optimization, and secure operation of electronics systems to communications, networking, and electronics industries. It operates through the Communications Solutions Group (CSG) and Electronic Industrial Solutions Group (EISG) segments. The CSG segment serves customers spanning the global commercial communications and aerospace, defense, and government end markets. The EISG segment offers test and measurement solutions across electronic industrial end markets, focusing on applications in the automotive, and energy industry and measurement solutions for semiconductor design and manufacturing, consumer electronics, education, and general electronics manufacturing. The company was founded by William R. Hewlett and David Packard in 1937 and is headquartered in Santa Rosa, CA.

Keysight Technologies Inc

Keysight Technologies is trending following a double-beat earnings report and a raised full-year guidance that signal sustained demand momentum in AI infrastructure and testing. Investors and community members are actively debating the sustainability of this growth cycle, with many analyzing the company's role as a key supplier within the SpaceX supply chain and broader AI ecosystem.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced financial results and business highlights for the three months ended March 31, 2026. Highlights...

Sensus Healthcare (SRTS) Projected to Post Earnings on Thursday

Sensus Healthcare (NASDAQ:SRTS) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...

Sensus Healthcare (NASDAQ:SRTS) Shares Pass Below 50-Day Moving Average   - Here's Why

Sensus Healthcare (NASDAQ:SRTS) Stock Passes Below Fifty Day Moving Average - Time to Sell...

Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced...

Sensus Healthcare, Inc. (NASDAQ:SRTS) Receives Average Rating of "Moderate Buy" from Analysts

Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six ratings firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned...

Sensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest Update

Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) saw a large decrease in short interest in March. As of March 13th, there was short interest totaling 394,950 shares, a decrease of 18.3% from the February 26th total of 483,655 shares. Currently, 2.6% of the company's shares are sold short...

Sensus Healthcare, Inc. (NASDAQ:SRTS) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of Sensus Healthcare, Inc. (NASDAQ:SRTS - Get Free Report) have been given an average rating of "Moderate Buy" by the six analysts that are currently covering the firm, MarketBeat.com reports...

Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced the filing of a lawsuit in the Circuit Court for the Fifteenth...

Sensus Healthcare (NASDAQ:SRTS) Now Covered by Analysts at Alliance Global Partners

Alliance Global Partners started coverage on Sensus Healthcare in a research report on Friday. They set a "buy" rating and a $7.50 price target for the company...

Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100 Installed Base

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological...

Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.

Current Price	$3.35
Prev Close	$3.47
Open	$3.46
Dividend Yield	0.00%
50-Day Moving Average	$3.99
Beta	0.84
Avg. Volume	35,472.74
PE Ratio	-7.06

52-Week High	$5.92
52-Week Low	$2.82
Market Capitalization	$57.12M
EPS (Annual)	-$0.4728
Price to Book	1.21
Revenue Per Employee	$458,033.33

SRTS
Sensus Healthcare Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SRTS News

SRTSSensus Healthcare Inc